David Bailey
Stock Analyst at Morgan Stanley
(3.57)
# 2,104
Out of 4,345 analysts
191
Total ratings
45.6%
Success rate
6.4%
Average return
Main Sectors:
Stocks Rated by David Bailey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Maintained: Buy | $40.00 | $37.82 | +5.76% | 10 | May 25, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Buy | $166.00 → $231.87 | $97.59 | +137.60% | 29 | May 24, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $22.40 | $13.30 | +68.42% | 14 | May 24, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Sell | $32.90 | $37.52 | -12.30% | 34 | May 20, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | n/a | $28.96 | - | 26 | May 20, 2026 | |
| ASX: ANN Ansell Limited | Maintained: Hold | $34.40 → $29.30 | $26.99 | +8.56% | 14 | May 6, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Downgraded: Sell | $25.20 → $20.30 | $18.74 | +8.35% | 18 | May 6, 2026 | |
| ASX: COH Cochlear Limited | Upgraded: Hold | $194.00 → $119.00 | $97.74 | +21.75% | 14 | Apr 23, 2026 | |
| RMD ResMed | Maintained: Buy | $310 | $206.10 | +50.41% | 14 | Mar 22, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Maintained: Buy | $2.90 | $2.11 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $127.50 → $152.50 | $130.21 | n/a | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.50 → $1.35 | $0.347 | n/a | 6 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.05 → $3.55 | $6.43 | n/a | 5 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.43 | n/a | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.36 | $2.58 | n/a | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.75 | $1.26 | n/a | 1 | Jan 21, 2021 |
Fisher & Paykel Healthcare Corporation Limited
May 25, 2026
Maintained: Buy
Price Target: $40.00
Current: $37.82
Upside: +5.76%
CSL Limited
May 24, 2026
Reiterated: Buy
Price Target: $166.00 → $231.87
Current: $97.59
Upside: +137.60%
Telix Pharmaceuticals Limited
May 24, 2026
Maintained: Buy
Price Target: $22.40
Current: $13.30
Upside: +68.42%
Ramsay Health Care Limited
May 20, 2026
Maintained: Sell
Price Target: $32.90
Current: $37.52
Upside: -12.30%
ResMed Inc.
May 20, 2026
Maintained: Buy
Price Target: n/a
Current: $28.96
Upside: -
Ansell Limited
May 6, 2026
Maintained: Hold
Price Target: $34.40 → $29.30
Current: $26.99
Upside: +8.56%
Sonic Healthcare Limited
May 6, 2026
Downgraded: Sell
Price Target: $25.20 → $20.30
Current: $18.74
Upside: +8.35%
Cochlear Limited
Apr 23, 2026
Upgraded: Hold
Price Target: $194.00 → $119.00
Current: $97.74
Upside: +21.75%
ResMed
Mar 22, 2026
Maintained: Buy
Price Target: $310
Current: $206.10
Upside: +50.41%
Integral Diagnostics Limited
Aug 28, 2024
Maintained: Buy
Price Target: $2.90
Current: $2.11
Upside: n/a
Aug 15, 2024
Maintained: Buy
Price Target: $127.50 → $152.50
Current: $130.21
Upside: n/a
Feb 28, 2024
Maintained: Hold
Price Target: $1.50 → $1.35
Current: $0.347
Upside: n/a
Jan 31, 2024
Maintained: Buy
Price Target: $3.05 → $3.55
Current: $6.43
Upside: n/a
Aug 24, 2021
Maintained: Hold
Price Target: n/a
Current: $13.43
Upside: n/a
Jan 21, 2021
Maintained: Hold
Price Target: $0.36
Current: $2.58
Upside: n/a
Jan 21, 2021
Downgraded: Hold
Price Target: $2.75
Current: $1.26
Upside: n/a